To functionally validate the biological roles of the 10 risk-score-associated genes in the GBM PN/MES subtype modulation, we selected two representative genes from the risk score formula, FGFR3 (a positive variable) and COL6A3 (a negative variable), for in vitro characterization. This evidence concerns the gene FGFR3 and glioblastoma.